An Observational Study to Describe in Routine Clinical Practice the Treatment Patterns of Usage of Biological DMARDs in RA Patients.
NCT ID: NCT02590562
Last Updated: 2017-08-02
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
808 participants
OBSERVATIONAL
2013-12-31
2014-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Predictability Studies on the Efficacy of TNF-α Inhibitors in Chinese RA From "Real World"
NCT02878161
Leflunomide EfficAcy Response Related to Dosing Regimen in Early Rheumatoid Arthritis
NCT00596206
Serum Biomarkers Analysis in Patients With AR Treated With Anti-TMF
NCT02804204
Prospective, Multi-Center, Observational, Whole Blood Specimen Collection Study in Participants with Rheumatoid Arthritis with Inadequate Response or Intolerance to a DMARD Starting a New BDMARD or TsDMARD Treatment +/- CsDMARD
NCT05936970
Study Conducted in Subjects With Rheumatoid Arthritis Who Have Moderate to Severe Disease Activity Despite Methotrexate Therapy With or Without Other Non Biologic Disease Modifying Antirheumatic Drugs (DMARDs)for at Least 12 Weeks Prior to Screening
NCT01578850
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
RA patients treated with routine clinical practice
Describe in routine clinical practice the treatment patterns of usage of biological DMARDs in patients suffering from RA including frequency of monotherapy, biological DMARDs usage status (types, dosage), concomitant DMARDs usage information (type and dosage)
Routine clinical practice
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Routine clinical practice
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with a diagnosis of RA according to the revised ACR criteria.
* Patients receiving treatment of launched biological DMARDs.
Exclusion Criteria
* Patients who are considered not appropriate for study due to other reasons at physicians' discretion.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hoffmann-La Roche
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clinical Trials
Role: STUDY_DIRECTOR
Hoffmann-La Roche
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Peking University First Hospital
Beijing, , China
Beijing Jishutan Hospital; Rheumatology & Immunology
Beijing, , China
Peking University People's Hospital
Beijing, , China
Peking University Third Hospital
Beijing, , China
China-Janpan Friendship Hospital of Jilin University
Changchun, , China
West China Hospital, Sichuan University
Chengdu, , China
Sichuan Provincial People's Hospital
Chengdu, , China
The First Affiliated Hospital, Sun Yat-sen University
Guangzhou, , China
The First Affiliated Hospital of Guangzhou University of Chinese Medicine
Guangzhou, , China
Nanfang Hospital, Southern Medical University
Guangzhou, , China
Guanghua Hospital of Integrated Traditional Chinese and Western Medicine ( Guanghua Hospital)
Shanghai, , China
The Second Hospital of Shanxi Medical University
Taiyuan, , China
Tianjin Medical University General Hospital
Tianjin (天津), , China
Xinjiang Uygur Autonomous Region People Hospital
Ürümqi, , China
First Affiliated Hospital of Medical College of Xi'an Jiaotong University
Xi'an, , China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ML28487
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.